Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ester wohlfarth (8 results)?
Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
Kresken M, Klare I, Wichelhaus TA, Wohlfarth E, Layer-Nicolaou F, Neumann B, Werner G; Study Group ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy. Kresken M, et al. Among authors: wohlfarth e. J Glob Antimicrob Resist. 2022 Mar;28:102-107. doi: 10.1016/j.jgar.2021.12.016. Epub 2021 Dec 25. J Glob Antimicrob Resist. 2022. PMID: 34958996 Free article.
In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany.
Kresken M, Wohlfarth E, Weikel C, Butler D, Pfeifer Y, Werner G; ‘Antimicrobial Resistance’ Study Group of the Paul Ehrlich Society for Infection Therapy. Kresken M, et al. Among authors: wohlfarth e. J Antimicrob Chemother. 2022 Dec 7:dkac406. doi: 10.1093/jac/dkac406. Online ahead of print. J Antimicrob Chemother. 2022. PMID: 36474310
The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019.
Wohlfarth E, Kresken M, Higgins PG, Stefanik D, Wille J, Hafner D, Körber-Irrgang B, Seifert H; Study Group “Antimicrobial Resistance” of the Paul-Ehrlich-Society for Infection Therapy. Wohlfarth E, et al. Int J Antimicrob Agents. 2022 Nov-Dec;60(5-6):106689. doi: 10.1016/j.ijantimicag.2022.106689. Epub 2022 Nov 12. Int J Antimicrob Agents. 2022. PMID: 36375774
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17.
Wohlfarth E, Kresken M, Deuchert F, Gatermann SG, Pfeifer Y, Pfennigwerth N, Seifert H, Higgins PG, Werner G, Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy. Wohlfarth E, et al. Antibiotics (Basel). 2023 May 6;12(5):864. doi: 10.3390/antibiotics12050864. Antibiotics (Basel). 2023. PMID: 37237767 Free PMC article.
11 results